Semnur Pharmaceuticals, Inc. Operating Expenses
Semnur Pharmaceuticals, Inc. (SMNR) reported Operating Expenses of $4.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- Semnur Pharmaceuticals, Inc. operating expenses for the quarter ending 2026-06-30 was $4.22M, a 322.82% increase year-over-year.
- Semnur Pharmaceuticals, Inc. operating expenses for the quarter ending 2026-03-31 was $4.58M, a 588.12% increase year-over-year.
- Semnur Pharmaceuticals, Inc. operating expenses for the quarter ending 2025-12-31 was $6.16M, a 693.56% increase year-over-year.
- Semnur Pharmaceuticals, Inc. operating expenses for the quarter ending 2025-09-30 was $152.59M, a 11656.09% increase year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.22M 10-Q · filed 2026-08-10 | $8.80M 10-Q · filed 2026-08-10 | $14.96M derived: sum of 3 quarters · filed 2026-08-10 | $167.55M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $4.58M 10-Q · filed 2026-05-13 | $10.73M derived: sum of 2 quarters · filed 2026-05-13 | $163.33M derived: sum of 3 quarters · filed 2026-05-13 | $164.33M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $6.16M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | $158.75M derived: sum of 2 quarters · filed 2026-05-12 | $159.75M derived: sum of 3 quarters · filed 2026-08-10 | $160.42M S-1 · filed 2026-05-12 |
| 2025-09-30 | $152.59M 10-Q · filed 2025-11-12 | $153.59M derived: sum of 2 quarters · filed 2026-08-10 | $154.26M 10-Q · filed 2025-11-12 | $155.03M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $999.00K 10-Q · filed 2026-08-10 | $1.66M 10-Q · filed 2026-08-10 | $2.44M derived: sum of 3 quarters · filed 2026-08-10 | $3.74M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $665.00K 10-Q · filed 2026-05-13 | $1.44M derived: sum of 2 quarters · filed 2026-05-13 | $2.74M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $776.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | $2.07M derived: sum of 2 quarters · filed 2026-05-12 | $4.69M S-1 · filed 2026-05-12 | |
| 2024-09-30 | $1.30M 10-Q · filed 2025-11-12 | $3.91M 10-Q · filed 2025-11-12 |